Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:36 UTC |
---|
HMDB ID | HMDB0014383 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nevirapine |
---|
Description | Nevirapine is only found in individuals that have used or taken this drug. It is a potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV infection and AIDS. [PubChem]Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme's catalytic site. The activity of nevirapine does not compete with template or nucleoside triphosphates. |
---|
Structure | CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1 InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20) |
---|
Synonyms | Value | Source |
---|
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one | ChEBI | NEV | ChEBI | NVP | ChEBI | Viramune | ChEBI | ABBR NVP | Kegg | Nevirapine hemihydrate | HMDB | BI RG 587 | HMDB | BIRG587 | HMDB | Hemihydrate, nevirapine | HMDB | BI-RG-587 | HMDB |
|
---|
Chemical Formula | C15H14N4O |
---|
Average Molecular Weight | 266.2979 |
---|
Monoisotopic Molecular Weight | 266.11676109 |
---|
IUPAC Name | 2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one |
---|
Traditional Name | nevirapine |
---|
CAS Registry Number | 129618-40-2 |
---|
SMILES | CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1 |
---|
InChI Identifier | InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20) |
---|
InChI Key | NQDJXKOVJZTUJA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alkyldiarylamines. These are tertiary alkylarylamines having two aryl and one alkyl groups attached to the amino group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic nitrogen compounds |
---|
Class | Organonitrogen compounds |
---|
Sub Class | Amines |
---|
Direct Parent | Alkyldiarylamines |
---|
Alternative Parents | |
---|
Substituents | - Alkyldiarylamine
- Pyrido-para-diazepine
- Para-diazepine
- Methylpyridine
- Imidolactam
- Pyridine
- Heteroaromatic compound
- Vinylogous amide
- Carboxamide group
- Lactam
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Azacycle
- Organoheterocyclic compound
- Organic oxygen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 196.06 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.1 g/L | Not Available | LogP | 2.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Nevirapine,1TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC=CN=C1N2C1CC1 | 2390.5 | Semi standard non polar | 33892256 | Nevirapine,1TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC=CN=C1N2C1CC1 | 2391.7 | Standard non polar | 33892256 | Nevirapine,1TMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C)C(=O)C1=CC=CN=C1N2C1CC1 | 3572.1 | Standard polar | 33892256 | Nevirapine,1TBDMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC=CN=C1N2C1CC1 | 2630.9 | Semi standard non polar | 33892256 | Nevirapine,1TBDMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC=CN=C1N2C1CC1 | 2594.6 | Standard non polar | 33892256 | Nevirapine,1TBDMS,isomer #1 | CC1=CC=NC2=C1N([Si](C)(C)C(C)(C)C)C(=O)C1=CC=CN=C1N2C1CC1 | 3625.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Nevirapine GC-MS (Non-derivatized) - 70eV, Positive | splash10-01s9-0890000000-c2ef64541073a1c774c3 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nevirapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nevirapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Nevirapine , positive-QTOF | splash10-016r-1390000000-cbb2d729a2b310bf5dd0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nevirapine , positive-QTOF | splash10-016r-0290000000-64af72aec31bfd168e68 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nevirapine , positive-QTOF | splash10-004i-3980000000-98e328d2867c43716973 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Nevirapine 35V, Positive-QTOF | splash10-00or-0390000000-8627dbd7619ad6589566 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 10V, Positive-QTOF | splash10-014i-0090000000-e341212035575baee47c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 20V, Positive-QTOF | splash10-014i-1090000000-aa8be82ca660a3a1654d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 40V, Positive-QTOF | splash10-0k96-9240000000-96f26abab0ca2960a8d9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 10V, Negative-QTOF | splash10-014i-0090000000-5ff2e0be399277e2d1e4 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 20V, Negative-QTOF | splash10-016r-0090000000-e6562b6940dd28d0a37b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 40V, Negative-QTOF | splash10-0a6r-1890000000-d60a9db4a4fef99e1ca5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 10V, Positive-QTOF | splash10-014i-0090000000-d1a08ff6bcda467abc31 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 20V, Positive-QTOF | splash10-016r-0090000000-ab3762b78a7dc338267f | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 40V, Positive-QTOF | splash10-004i-0390000000-40b55ad31c970d6bd2e3 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 10V, Negative-QTOF | splash10-014i-0090000000-b7ee7f3fd2558633e840 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 20V, Negative-QTOF | splash10-014i-0090000000-b8840f336feb8c33bccc | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nevirapine 40V, Negative-QTOF | splash10-0092-2950000000-37fa8e70d7fa15c73439 | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|